NewsBenzingaCoya Therapeutics宣布其用于评估COYA 302潜在治疗肌萎缩侧索硬化症的2/3期ALSTARS试验计划入组的120名受试者已全部完成入组 Coya Therapeutics宣布其用于评估COYA 302潜在治疗肌萎缩侧索硬化症的2/3期ALSTARS试验计划入组的120名受试者已全部完成入组 Benzinga 2026.10.05 12:03 (GMT+0) Open on Benzinga Other news Dow Jones Today: DJIA Flat as Oil Edges Lower; Tech Stocks Rebound - TipRanks.com Gas Never Used To Be This Pricey In October; West Coast Imports Are Surging Wells Fargo Maintains Equal-Weight on Sonoco Products, Lowers Price Target to $53 Piper Sandler Maintains Neutral on WaFd, Lowers Price Target to $31 INTC vs. AMD: Which AI Chip Stock Could Continue to Rally After Today? - TipRanks.com VinFast Says Real Estate Could Cover Its EV Cash Burn
